← Back to Dividend Calendar

Gilead Sciences Inc

GILDNASDAQ

HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Market Cap

$181.25B

Revenue (TTM)

$29.44B

EBITDA

$14.58B

Profit Margin

28.9%

P/E Ratio

21.57

Earnings Growth (YoY)

23.4%

Return on Equity

40.7%

Dividend Yield

2.1%

Upcoming Events (1)Past Events (0)

Earnings Report

Gilead Sciences

TBD

Report Date:

Fiscal Period:

EPS Estimate:

Rev. Estimate:

Price Target:

Oct 22, 2026

Q3 2026

$2.12(prior yr: $2.47)

$7.8B

$159.11